• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form N-PX filed by The Carlyle Group Inc.

    8/22/25 4:41:19 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    Form N-PX Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM N-PX
    ANNUAL REPORT OF PROXY VOTING RECORD
    OMB APPROVAL


    Form N-PX

    OMB Number:  3235-0582


    Estimated average burden hours per response: 20.8

    N-PX: Filer Information

    Filer CIK
    0001527166 
    Filer CCC
    ********  
    Date of Report
    06/30/2025 
    Are you a Registered Management Investment Company or an Institutional Manager?
    Institutional Manager 
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST
    Is this an electronic copy of an official filing submitted in paper format? Checkbox not checked

    Submission Contact Information

    Name
     
    Phone Number
     
    E-mail Address
     

    Notification Information

    Notify via Filing Website only?Checkbox not checked

    N-PX: Cover Page

    Name and address of reporting person:

    Name of reporting person (For registered management investment companies, provide exact name of registrant as specified in charter)

    Carlyle Group Inc. 

    Street 1

    C/O THE CARLYLE GROUP 

    Street 2

    1001 PENNSYLVANIA AVENUE, N.W. 

    City

    WASHINGTON 

    State/Country

    DISTRICT OF COLUMBIA  

    Zip code and zip code extension or foreign postal code

    20004 

    Telephone number of reporting person, including area code:

    202-729-5626 

    Name and address of agent for service:

    Name of agent for service

     

    Street 1

     

    Street 2

     

    City

     

    State/Country

     

    Zip code and zip code extension or foreign postal code

     

    Reporting Period:Report for the year ended June 30, 2025 
    SEC Investment Company Act or Form 13F File Number:

    028-15025 

    CRD Number (if any):

    000111128 

    Other SEC File Number (if any):

    801-52462 

    Legal Entity Identifier (if any):

     

    Report Type (check only one):

    Registered Management Investment Company.
    Radio button not checked Fund Voting Report (Check here if the registered management investment company held one or more securities it was entitled to vote.)
    Radio button not checked Fund Notice Report (Check here if the registered management investment company did not hold any securities it was entitled to vote.)
    Institutional Manager.
    Radio button not checked Institutional Manager Voting Report (Check here if all proxy votes of this reporting manager are reported in this report.)
    Radio button not checked Institutional Manager Notice Report (Check here if no proxy votes are reported in this report and complete the notice report filing explanation section below)
    Radio button checked Institutional Manager Combination Report (Check here if a portion of the proxy votes for this reporting manager are reported in this report and a portion are reported by other reporting person(s).)

    Other Persons Reporting for this Manager:1

    Investment Company Act or Form 13F File Number:

    028-15646 

    CRD Number (if any):

    000159215 

    Other SEC File Number (if any):

    801-72890 

    LEI (if any):

     

    Name:

    AlpInvest Partners B.V. 

    Do you wish to provide explanatory information pursuant to Special Instruction B.4?: Radio button checked Yes Radio button not checked No
    Additional information:

    Explanatory Note 1 AlpInvest Partners B.V. is an indirectly wholly owned investment adviser of The Carlyle Group Inc. However, The Carlyle Group Inc. does not excercise any voting power over the shares held by AlpInvest Partners B.V. --- Explanatory Note 2 In August 2022, The Carlyle Group Inc. completed its acquisition of the Abingworth group, a life sciences investment firm. As a result of the acquisition, Abingworth LLP became a relying advisor of Carlyle Investment Management L.L.C. 

    N-PX: Summary - Included Managers

    Number of Included Institutional Managers:

    3 

    Included Institutional Managers:1

    No.:

    1 

    Form 13F File Number [028-]:

    028-14285 

    CRD Number (if any):

    000163213 

    SEC File Number (if any):

    802-75741 

    LEI (if any):

     

    Name:

    Abingworth LLP 

    Included Institutional Managers:2

    No.:

    2 

    Form 13F File Number [028-]:

    028-12429 

    CRD Number (if any):

    000111128 

    SEC File Number (if any):

    801-52462 

    LEI (if any):

     

    Name:

    Carlyle Investment Management LLC 

    Included Institutional Managers:3

    No.:

    3 

    Form 13F File Number [028-]:

    028-15024 

    CRD Number (if any):

    000114795 

    SEC File Number (if any):

     

    LEI (if any):

     

    Name:

    CIM Global, L.L.C. 

    N-PX: Signature Block

    Reporting Person:

    Carlyle Group Inc. 

    By (Signature):

    Jeffrey W. Ferguson 

    By (Printed Signature):

    Jeffrey W. Ferguson 

    By (Title):

    General Counsel 

    Date:

    08/22/2025 

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    More analyst ratings

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:37:43 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-Q filed by The Carlyle Group Inc.

    10-Q - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:11:15 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Resonetics to Acquire Resolution Medical, Expanding Capabilities in Neuromodulation and Structural Heart Markets

    NASHUA, N.H., Jan. 27, 2026 /PRNewswire/ -- Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution Medical is headquartered in Fridley, MN, with additional operations in the Netherlands, and is currently owned by Arcline Investment Management. The transaction adds complementary capabilities in high-growth therapeutic markets, including neuromodulation, structural heart, and interventional cardiology to current Resonetics offerings. The

    1/27/26 2:00:00 PM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 111,994,953 shares and disposed of 55,557,381 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    1/21/26 4:30:21 PM ET
    $CG
    Investment Managers
    Finance

    New insider Nedelman Jeffrey claimed ownership of 1,499,881 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:07:52 PM ET
    $CG
    Investment Managers
    Finance

    New insider Jenkins Mark David claimed ownership of 1,414,484 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:06:28 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer

    MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

    1/14/26 9:35:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Credit Income Fund Schedules First Quarter 2026 Financial Results and Investor Conference Call

    NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday, February 25, 2026, for its first quarter of 2026. CCIF will host a conference call at 10:00 a.m. EST on Thursday, February 26, 2026, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and a replay will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed

    1/22/26 4:10:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance